TMDX
TransMedics Group, Inc.
Price Chart
Latest Quote
$80.53
+7.31 (+9.98%)
Current Price
| Previous Close | $73.22 |
| Open | $75.26 |
| Day High | $80.72 |
| Day Low | $75.12 |
| Volume | 510,951 |
Stock Information
| Shares Outstanding | 34.56M |
| Total Debt | $863.41M |
| Cash Equivalents | $461.74M |
| Revenue | $635.89M |
| Net Income | $171.92M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $2.78B |
| P/E Ratio | 18.43 |
| EPS (TTM) | $4.37 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.02B |
| Sales | $635.89M |
| Income | $171.92M |
| Book/sh | $13.81 |
| Cash/sh | $13.36 |
| Employees | 898 |
Financial Ratios
| Quick Ratio | 6.01 |
| Current Ratio | 6.74 |
| Debt/Eq | 174.78 |
| EPS Growth TTM | -71.50% |
Returns & Margins
| ROA | 5.20% |
| ROE | 45.22% |
| Gross Margin | 59.09% |
| Operating Margin | 7.65% |
| Profit Margin | 27.04% |
Ownership
| Insider Ownership | 3.40% |
| Institutional Ownership | 108.87% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 24.44 |
| P/S | 4.38 |
| P/B | 5.83 |
Analyst Data
| Recommendation | buy |
| Target Price | $116.78 |
Technical Indicators
| SMA20 | $71.58 |
| SMA50 | $84.41 |
| SMA200 | $115.06 |
| RSI | 75.51 |
| ATR | 4.4186 |
| Shares Float | 33.44M |
| Short Float | 33.20% |
| Short Ratio | 3.88 |
| Volatility | 1.88 |
| Rel Volume | 0.47 |
Performance History
| Week | +9.43% |
| Month | +21.78% |
| Quarter | -29.19% |
| 6 Months | -35.60% |
| YTD | -34.36% |
| Year | -40.87% |
| 3 Years | -4.04% |
| 5 Years | +184.46% |
| 10 Years | +260.15% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $80.53 | 510,951 |
| 2026-06-17 | $73.22 | 862,700 |
| 2026-06-16 | $75.82 | 658,200 |
| 2026-06-15 | $75.48 | 948,100 |
| 2026-06-12 | $72.91 | 658,900 |
| 2026-06-11 | $73.59 | 941,500 |
| 2026-06-10 | $74.77 | 1,104,300 |
| 2026-06-09 | $74.29 | 1,254,800 |
| 2026-06-08 | $71.14 | 1,121,700 |
| 2026-06-05 | $69.43 | 1,042,900 |
| 2026-06-04 | $71.37 | 908,500 |
| 2026-06-03 | $69.69 | 1,171,100 |
| 2026-06-02 | $68.45 | 1,382,900 |
| 2026-06-01 | $67.53 | 1,332,400 |
| 2026-05-29 | $67.20 | 1,272,400 |
| 2026-05-28 | $67.83 | 1,597,300 |
| 2026-05-27 | $70.15 | 1,350,100 |
| 2026-05-26 | $70.46 | 1,554,800 |
| 2026-05-22 | $68.93 | 1,151,200 |
| 2026-05-21 | $68.85 | 989,500 |
| 2026-05-20 | $68.00 | 1,313,300 |
| 2026-05-19 | $66.13 | 1,448,700 |
| 2026-05-18 | $68.34 | 1,943,200 |
About TransMedics Group, Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
đ° Latest News
Will Analyst Focus on TransMedicsâ OCS Platform and Financial Metrics Change TransMedics Groupâs (TMDX) Narrative?
Simply Wall St. âĸ 2026-06-06T20:17:58Z
TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?
Zacks âĸ 2026-06-04T15:30:29Z
Reasons to Retain TransMedics Stock in Your Portfolio for Now
Zacks âĸ 2026-05-28T16:59:00Z
Assessing TransMedics Group (TMDX) Valuation After A Sharp One Year Share Price Decline
Simply Wall St. âĸ 2026-05-10T05:15:18Z
TransMedics Group Inc (TMDX) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...
GuruFocus.com âĸ 2026-05-08T15:00:26ZGlucotrack Submits Blood Glucose Monitoring Technology to FDA
Exec Edge âĸ 2026-05-07T19:50:42Z
My Top 3 Stocks to Buy in May
Motley Fool âĸ 2026-05-07T09:04:00Z
TMDX Dips After Posting Q1 Earnings & Revenue Miss, Margins Fall
Zacks âĸ 2026-05-06T15:54:00Z
TransMedics (TMDX) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-06T14:41:47Z
AMD upgraded, Reddit downgraded: Wall Street's top analyst calls
The Fly âĸ 2026-05-06T13:38:53Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $242,688,000 | $179,459,000 | $87,530,000 | $28,187,000 |
| Cost Of Revenue | $242,688,000 | $179,459,000 | $87,530,000 | $28,187,000 |
| Total Revenue | $605,494,000 | $441,540,000 | $241,623,000 | $93,459,000 |
| Operating Revenue | $605,494,000 | $441,354,000 | $241,601,000 | $92,079,000 |
| Expenses | ||||
| Interest Expense | $13,782,000 | $14,409,000 | $10,791,000 | $3,726,000 |
| Total Expenses | $496,911,000 | $404,044,000 | $270,350,000 | $124,896,000 |
| Other Income Expense | $12,721,000 | $12,693,000 | $12,847,000 | $-1,002,000 |
| Other Non Operating Income Expenses | $12,721,000 | $12,693,000 | $12,847,000 | $-1,002,000 |
| Net Non Operating Interest Income Expense | $-13,782,000 | $-14,409,000 | $-10,791,000 | $-3,726,000 |
| Interest Expense Non Operating | $13,782,000 | $14,409,000 | $10,791,000 | $3,726,000 |
| Operating Expense | $254,223,000 | $224,585,000 | $182,820,000 | $96,709,000 |
| Selling And Marketing Expense | $4,316,000 | - | - | $18,209,000 |
| General And Administrative Expense | $180,852,000 | $168,617,000 | $119,553,000 | $51,688,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $190,291,000 | $35,464,000 | $-25,028,000 | $-36,231,000 |
| Net Interest Income | $-13,782,000 | $-14,409,000 | $-10,791,000 | $-3,726,000 |
| Normalized Income | $190,291,000 | $35,464,000 | $-25,028,000 | $-36,231,000 |
| Net Income From Continuing And Discontinued Operation | $190,291,000 | $35,464,000 | $-25,028,000 | $-36,231,000 |
| Total Operating Income As Reported | $108,583,000 | $37,496,000 | $-28,727,000 | $-31,437,000 |
| Net Income Common Stockholders | $190,291,000 | $35,464,000 | $-25,028,000 | $-36,231,000 |
| Net Income | $190,291,000 | $35,464,000 | $-25,028,000 | $-36,231,000 |
| Net Income Including Noncontrolling Interests | $190,291,000 | $35,464,000 | $-25,028,000 | $-36,231,000 |
| Net Income Continuous Operations | $190,291,000 | $35,464,000 | $-25,028,000 | $-36,231,000 |
| Pretax Income | $107,522,000 | $35,780,000 | $-26,671,000 | $-36,165,000 |
| Operating Income | $108,583,000 | $37,496,000 | $-28,727,000 | $-31,437,000 |
| Gross Profit | $362,806,000 | $262,081,000 | $154,093,000 | $65,272,000 |
| Interest Income | - | - | $12,500,000 | $900,000 |
| Special Income Charges | - | - | $-27,212,000 | $-600,000 |
| Interest Income Non Operating | - | - | $12,500,000 | $900,000 |
| Per Share | ||||
| Diluted EPS | $4.87 | $1.01 | $-0.77 | $-1.23 |
| Basic EPS | $5.60 | $1.07 | $-0.77 | $-1.23 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $148,489,000 | $69,947,000 | $-7,703,000 | $-28,961,000 |
| Reconciled Depreciation | $27,185,000 | $19,758,000 | $8,177,000 | $3,478,000 |
| EBITDA (Bullshit earnings) | $148,489,000 | $69,947,000 | $-7,703,000 | $-28,961,000 |
| EBIT | $121,304,000 | $50,189,000 | $-15,880,000 | $-32,439,000 |
| Diluted Average Shares | $40,540,694 | $35,216,837 | $32,517,372 | $29,556,633 |
| Basic Average Shares | $33,993,468 | $33,229,953 | $32,517,372 | $29,556,633 |
| Diluted NI Availto Com Stockholders | $190,291,000 | $35,464,000 | $-25,028,000 | $-36,231,000 |
| Tax Provision | $-82,769,000 | $316,000 | $-1,643,000 | $66,000 |
| Research And Development | $69,055,000 | $55,968,000 | $63,267,000 | $26,812,000 |
| Selling General And Administration | $185,168,000 | $168,617,000 | $119,553,000 | $69,897,000 |
| Other Gand A | $66,346,000 | $59,142,000 | $46,836,000 | $12,338,000 |
| Salaries And Wages | $114,506,000 | $109,475,000 | $72,717,000 | $39,350,000 |
| Total Unusual Items | - | - | $300,000 | $-1,900,000 |
| Total Unusual Items Excluding Goodwill | - | - | $300,000 | $-1,900,000 |
| Other Special Charges | - | - | $27,212,000 | $600,000 |
| Gain On Sale Of Security | - | - | $300,000 | $-1,300,000 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $459,603,000 | $214,902,000 | $122,858,000 | $187,375,000 |
| Total Assets | $1,068,373,000 | $804,076,000 | $706,047,000 | $277,147,000 |
| Total Non Current Assets | $430,590,000 | $306,860,000 | $195,393,000 | $24,853,000 |
| Other Non Current Assets | $739,000 | $708,000 | $562,000 | $500,000 |
| Non Current Deferred Assets | $83,543,000 | $0 | - | - |
| Non Current Deferred Taxes Assets | $83,543,000 | $0 | - | - |
| Goodwill And Other Intangible Assets | $13,497,000 | $13,701,000 | $14,344,000 | $0 |
| Other Intangible Assets | $1,948,000 | $2,152,000 | $2,354,000 | - |
| Current Assets | $637,783,000 | $497,216,000 | $510,654,000 | $252,294,000 |
| Other Current Assets | $16,254,000 | $16,290,000 | $8,031,000 | $2,896,000 |
| Inventory | $48,881,000 | $46,554,000 | $44,235,000 | $20,605,000 |
| Receivables | $84,282,000 | $97,722,000 | $63,576,000 | $27,611,000 |
| Accounts Receivable | $84,282,000 | $97,722,000 | $63,576,000 | $27,611,000 |
| Cash Cash Equivalents And Short Term Investments | $488,366,000 | $336,650,000 | $394,812,000 | $201,182,000 |
| Cash And Cash Equivalents | $488,366,000 | $336,650,000 | $394,812,000 | $201,182,000 |
| Cash Financial | $488,366,000 | $336,650,000 | $394,812,000 | $201,182,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $24,025,000 | $172,661,000 | $111,392,000 | - |
| Total Debt | $519,278,000 | $518,287,000 | $515,946,000 | $67,555,000 |
| Long Term Debt And Capital Lease Obligation | $505,968,000 | $515,560,000 | $513,911,000 | $66,111,000 |
| Long Term Debt | $502,391,000 | $509,311,000 | $506,204,000 | $58,696,000 |
| Current Debt And Capital Lease Obligation | $13,310,000 | $2,727,000 | $2,035,000 | $1,444,000 |
| Current Debt | $10,000,000 | - | - | - |
| Other Current Borrowings | $10,000,000 | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $595,273,000 | $575,473,000 | $568,845,000 | $89,772,000 |
| Total Non Current Liabilities Net Minority Interest | $505,968,000 | $515,560,000 | $513,911,000 | $66,111,000 |
| Current Liabilities | $89,305,000 | $59,913,000 | $54,934,000 | $23,661,000 |
| Current Deferred Liabilities | $2,905,000 | $1,742,000 | $1,961,000 | $241,000 |
| Payables And Accrued Expenses | $73,090,000 | $55,444,000 | $50,938,000 | $21,976,000 |
| Payables | $10,350,000 | $10,292,000 | $12,717,000 | $3,341,000 |
| Accounts Payable | $10,350,000 | $10,292,000 | $12,717,000 | $3,341,000 |
| Non Current Deferred Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $473,100,000 | $228,603,000 | $137,202,000 | $187,375,000 |
| Total Equity Gross Minority Interest | $473,100,000 | $228,603,000 | $137,202,000 | $187,375,000 |
| Stockholders Equity | $473,100,000 | $228,603,000 | $137,202,000 | $187,375,000 |
| Gains Losses Not Affecting Retained Earnings | $124,000 | $-364,000 | $-199,000 | $-225,000 |
| Other Equity Adjustments | $124,000 | $-364,000 | $-199,000 | $-225,000 |
| Retained Earnings | $-277,950,000 | $-468,241,000 | $-503,705,000 | $-478,677,000 |
| Other | ||||
| Ordinary Shares Number | $34,267,802 | $33,617,972 | $32,670,803 | $32,141,368 |
| Share Issued | $34,267,802 | $33,617,972 | $32,670,803 | $32,141,368 |
| Tangible Book Value | $459,603,000 | $214,902,000 | $122,858,000 | $187,375,000 |
| Invested Capital | $985,491,000 | $737,914,000 | $643,406,000 | $246,071,000 |
| Working Capital | $548,478,000 | $437,303,000 | $455,720,000 | $228,633,000 |
| Capital Lease Obligations | $6,887,000 | $8,976,000 | $9,742,000 | $8,859,000 |
| Total Capitalization | $975,491,000 | $737,914,000 | $643,406,000 | $246,071,000 |
| Capital Stock | $750,926,000 | $697,208,000 | $641,106,000 | $666,277,000 |
| Common Stock | $750,926,000 | $697,208,000 | $641,106,000 | $666,277,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $3,577,000 | $6,249,000 | $7,707,000 | $7,415,000 |
| Current Deferred Revenue | $2,905,000 | $1,742,000 | $1,961,000 | $241,000 |
| Current Capital Lease Obligation | $3,310,000 | $2,727,000 | $2,035,000 | $1,444,000 |
| Current Accrued Expenses | $62,740,000 | $45,152,000 | $38,221,000 | $18,635,000 |
| Goodwill | $11,549,000 | $11,549,000 | $11,990,000 | $0 |
| Net PPE | $332,811,000 | $292,451,000 | $180,487,000 | $24,353,000 |
| Accumulated Depreciation | $-66,065,000 | $-40,714,000 | $-21,293,000 | $-13,129,000 |
| Gross PPE | $398,876,000 | $333,165,000 | $201,780,000 | $37,482,000 |
| Leases | $25,113,000 | $22,949,000 | $13,354,000 | $12,415,000 |
| Construction In Progress | $2,174,000 | $6,658,000 | $6,250,000 | $482,000 |
| Other Properties | $45,544,000 | $39,074,000 | $29,810,000 | $20,400,000 |
| Machinery Furniture Equipment | $323,393,000 | $264,484,000 | $152,366,000 | $4,185,000 |
| Land And Improvements | $2,652,000 | $0 | - | - |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $20,626,000 | $15,253,000 | $14,606,000 | $7,790,000 |
| Work In Process | $2,006,000 | $3,274,000 | $3,806,000 | $1,876,000 |
| Raw Materials | $26,249,000 | $28,027,000 | $25,823,000 | $10,939,000 |
| Treasury Shares Number | - | - | $0 | - |
| Other Short Term Investments | - | - | - | $0 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $133,589,000 | $-80,941,000 | $-192,087,000 | $-57,724,000 |
| Operating Activities | ||||
| Operating Cash Flow | $192,840,000 | $48,803,000 | $-13,028,000 | $-45,817,000 |
| Cash Flow From Continuing Operating Activities | $192,840,000 | $48,803,000 | $-13,028,000 | $-45,817,000 |
| Operating Gains Losses | $-1,542,000 | $682,000 | $-342,000 | $1,811,000 |
| Investing Activities | ||||
| Capital Expenditure | $-59,251,000 | $-129,744,000 | $-179,059,000 | $-11,907,000 |
| Investing Cash Flow | $-59,251,000 | $-129,303,000 | $-193,953,000 | $54,513,000 |
| Cash Flow From Continuing Investing Activities | $-59,251,000 | $-129,303,000 | $-193,953,000 | $54,513,000 |
| Financing Activities | ||||
| Financing Cash Flow | $16,857,000 | $22,874,000 | $400,418,000 | $167,927,000 |
| Cash Flow From Continuing Financing Activities | $16,857,000 | $22,874,000 | $400,418,000 | $167,927,000 |
| Net Other Financing Charges | $-138,000 | - | $-52,072,000 | - |
| Issuance Of Capital Stock | - | $0 | $0 | $139,854,000 |
| Net Common Stock Issuance | - | $0 | $0 | $139,854,000 |
| Common Stock Issuance | - | $0 | $0 | $139,854,000 |
| Other | ||||
| Issuance Of Debt | $0 | $0 | $445,380,000 | $58,509,000 |
| Interest Paid Supplemental Data | $10,702,000 | $11,297,000 | $8,089,000 | $3,260,000 |
| End Cash Position | $488,866,000 | $337,150,000 | $395,312,000 | $201,682,000 |
| Beginning Cash Position | $337,150,000 | $395,312,000 | $201,682,000 | $26,080,000 |
| Effect Of Exchange Rate Changes | $1,270,000 | $-536,000 | $193,000 | $-1,021,000 |
| Changes In Cash | $150,446,000 | $-57,626,000 | $193,437,000 | $176,623,000 |
| Proceeds From Stock Option Exercised | $16,995,000 | $22,874,000 | $7,110,000 | $5,614,000 |
| Net Issuance Payments Of Debt | $0 | $0 | $445,380,000 | $22,459,000 |
| Net Long Term Debt Issuance | $0 | $0 | $445,380,000 | $22,459,000 |
| Long Term Debt Issuance | $0 | $0 | $445,380,000 | $58,509,000 |
| Net Business Purchase And Sale | $0 | $441,000 | $-14,894,000 | $0 |
| Sale Of Business | $0 | $441,000 | - | $0 |
| Net Intangibles Purchase And Sale | $0 | $0 | $-27,212,000 | $0 |
| Purchase Of Intangibles | $0 | $0 | $-27,212,000 | $0 |
| Net PPE Purchase And Sale | $-59,251,000 | $-129,744,000 | $-151,847,000 | $-11,907,000 |
| Purchase Of PPE | $-59,251,000 | $-129,744,000 | $-151,847,000 | $-11,907,000 |
| Change In Working Capital | $18,376,000 | $-45,000,000 | $-44,347,000 | $-26,759,000 |
| Change In Other Working Capital | $1,144,000 | $-203,000 | $83,000 | - |
| Change In Other Current Liabilities | $-2,895,000 | $-2,265,000 | $-1,574,000 | $255,000 |
| Change In Other Current Assets | $-23,000 | $-149,000 | $-54,000 | $0 |
| Change In Payables And Accrued Expense | $17,675,000 | $6,542,000 | $21,207,000 | $167,000 |
| Change In Accrued Expense | $17,694,000 | $7,938,000 | $14,250,000 | $3,437,000 |
| Change In Payable | $-19,000 | $-1,396,000 | $6,957,000 | $-3,270,000 |
| Change In Account Payable | $-19,000 | $-1,396,000 | $6,957,000 | $-3,270,000 |
| Change In Prepaid Assets | $-3,759,000 | $-6,262,000 | $-2,101,000 | $2,521,000 |
| Change In Inventory | $-7,716,000 | $-8,353,000 | $-28,092,000 | $-8,024,000 |
| Change In Receivables | $13,950,000 | $-34,310,000 | $-33,816,000 | $-21,678,000 |
| Changes In Account Receivables | $13,950,000 | $-34,310,000 | $-33,816,000 | $-21,678,000 |
| Other Non Cash Items | $5,212,000 | $4,675,000 | $30,381,000 | $1,182,000 |
| Stock Based Compensation | $36,861,000 | $33,224,000 | $19,791,000 | $10,321,000 |
| Deferred Tax | $-83,543,000 | $0 | $-1,660,000 | $0 |
| Deferred Income Tax | $-83,543,000 | $0 | $-1,660,000 | $0 |
| Depreciation Amortization Depletion | $27,185,000 | $19,758,000 | $8,177,000 | $3,478,000 |
| Depreciation And Amortization | $27,185,000 | $19,758,000 | $8,177,000 | $3,478,000 |
| Net Foreign Currency Exchange Gain Loss | $-1,622,000 | $665,000 | $-342,000 | $1,129,000 |
| Gain Loss On Sale Of PPE | $80,000 | $17,000 | $0 | $0 |
| Net Income From Continuing Operations | $190,291,000 | $35,464,000 | $-25,028,000 | $-36,231,000 |
| Repayment Of Debt | - | $0 | $0 | $-36,050,000 |
| Long Term Debt Payments | - | $0 | $0 | $-36,050,000 |
| Net Investment Purchase And Sale | - | $0 | $0 | $66,420,000 |
| Sale Of Investment | - | $0 | $0 | $76,916,000 |
| Purchase Of Investment | - | $0 | $0 | $-10,496,000 |
| Amortization Of Securities | - | $0 | $0 | $381,000 |
| Purchase Of Business | - | - | $-14,894,000 | $0 |
| Gain Loss On Investment Securities | - | - | - | $107,000 |
Fetched: 2026-06-17